🎯 check GDC-0077 (Inavolisib) product page
GDC-0077 (Inavolisib) is a potent, selective, ATP-competitive PI3Kα inhibitor. It blocks PI3K/AKT/mTOR signaling by promoting mutated p110α degradation, effectively inhibiting proliferation and inducing apoptosis in PIK3CA-mutated cancer cells.